NCT00129168View on ClinicalTrials.gov

Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Leukemia, Myeloid
Interventions
DRUG

Zosuquidar

DRUG

Daunorubicin

DRUG

Cytarabine

Sponsors
All Listed Sponsors
lead

Kanisa Pharmaceuticals

INDUSTRY